Imatinib attenuates monocrotaline pulmonary hypertension and has potent vasodilator activity in pulmonary and systemic vascular beds in the rat.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  2013-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1152/ajpheart.00329.2013PMID 23997103PMCID PMC3840242
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of erectile responses to imatinib in the rat.

  2013cited by this paper
• Imatinib mesylate (Gleevec) induces human corpus cavernosum relaxation by inhibiting receptor tyrosine kinases (RTKs): identification of new RTK targets.

  2013cited by this paper
• Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension: Results of the Randomized IMPRES Study

  2013cited by this paper
• The effects of the c-kit blocker glivec on the contractile response of urinary bladder.

  2011cited by this paper
• Complex effects of imatinib on spontaneous and oxytocin-induced contractions in human non-pregnant myometrium.

  2011cited by this paper
• Imatinib mesylate (Gleevec) as protein-tyrosine kinase inhibitor elicits smooth muscle relaxation in isolated human prostatic tissue.

  2011cited by this paper
• Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase activator, BAY 60-2770, are not dependent on endogenous nitric oxide or reduced heme.

  2011cited by this paper
• Tyrosine kinase inhibitors are potent acute pulmonary vasodilators in rats.

  2011cited by this paper
• Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.

  2010cited by this paper
• A protein tyrosine kinase inhibitor, imatinib mesylate (Gleevec), improves erectile and vascular function secondary to a reduction of hyperglycemia in diabetic rats.

  2010cited by this paper
• Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib.

  2010cited by this paper
• Role for tyrosine kinases in contraction of rat penile small arteries.

  2010cited by this paper
• Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized rat.

  2008cited by this paper
• Inhibitory effects of genistein and resveratrol on guinea pig gallbladder contractility in vitro.

  2008cited by this paper
• Receptor tyrosine kinases: mechanisms of activation and signaling.

  2007cited by this paper
• BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia.

  2007cited by this paper
• The functional effects of a c‐kit tyrosine inhibitor on guinea‐pig and human detrusor

  2006cited by this paper
• The Effect of Imatinib Mesylate on the Contractility of Isolated Rabbit Myometrial Strips

  2006cited by this paper
• Imatinib inhibits spontaneous rhythmic contractions of human uterus and intestine.

  2006cited by this paper
• Reversal of experimental pulmonary hypertension by PDGF inhibition.

  2005cited by this paper
• Antiproliferative effects of calcitonin gene-related peptide in aortic and pulmonary artery smooth muscle cells.

  2005cited by this paper
• Imatinib for the treatment of pulmonary arterial hypertension.

  2005cited by this paper
• Impairment of EDR by a long-term PDGF treatment in organ-cultured rabbit mesenteric artery.

  1999cited by this paper
• Mechanism of action and in vivo role of platelet-derived growth factor.

  1999cited by this paper
• CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins.

  1997cited by this paper
• Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

  1996cited by this paper
• Increase in tone and intracellular Ca2+ in rabbit isolated ear artery by platelet‐derived growth factor

  1995cited by this paper
• Induction of platelet-derived growth factor alpha- and beta-receptor mRNA and protein by platelet-derived growth factor BB.

  1991cited by this paper
• Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction.

  1985cited by this paper
• Changes in Pulmonary Blood Flow Affect Vascular Response to Chronic Hypoxia in Rats

  1983cited by this paper
• Hypoxia-induced structural changes in the media and adventitia of the rat hilar pulmonary artery and their regression.

  1980cited by this paper
• Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features.

  1979cited by this paper

• Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study

  2025cites this paper
• Exploring Novel Therapeutics for Pulmonary Arterial Hypertension.

  2025cites this paper
• Growth factors involved in vascular remodeling in pulmonary arterial hypertension

  2025cites this paper
• Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical Studies

  2025cites this paper
• Engineered pulmonary artery tissues for measuring contractility, drug testing and disease modelling

  2025cites this paper
• Nebulisation of Paclitaxel, Sotatercept and Iloprost for pulmonary hypertension for lung cancer. From In vitro to In vivo

  2024cites this paper
• Searching for Old and New Small-Molecule Protein Kinase Inhibitors as Effective Treatments in Pulmonary Hypertension—A Systematic Review

  2024cites this paper
• Inhaled nintentanib, pirfenidone and macitentan for pulmonary fibrosis: a laboratory experiment.

  2023cites this paper
• Imatinib attenuates reperfusion injury in a rat model of acute myocardial infarction

  2023cites this paper
• Receptor Tyrosine Kinase: Still an Interesting Target to Inhibit the Proliferation of Vascular Smooth Muscle Cells

  2023cites this paper
• Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca2+-sensitisation

  2022cites this paper
• Selective Src-Family B Kinase Inhibition Promotes Pulmonary Artery Endothelial Cell Dysfunction

  2021cites this paper
• The expression of ATP-sensitive potassium channels in human umbilical arteries with severe pre-eclampsia

  2021cites this paper
• Endothelial platelet-derived growth factor-mediated activation of smooth muscle platelet-derived growth factor receptors in pulmonary arterial hypertension

  2020influential citation
• The potential effect of imatinib against hypercholesterolemia induced atherosclerosis, endothelial dysfunction and hepatic injury in rabbits.

  2020cites this paper
• Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors

  2020cites this paper
• Tyrosine kinase inhibitors relax pulmonary arteries in human and murine precision-cut lung slices

  2019influential citation
• Platelet‐derived growth factor up‐regulates Ca2+‐sensing receptors in idiopathic pulmonary arterial hypertension

  2019cites this paper
• Redox Regulation of Ion Channels and Receptors in Pulmonary Hypertension

  2019cites this paper
• Nintedanib ameliorates experimental pulmonary arterial hypertension via inhibition of endothelial mesenchymal transition and smooth muscle cell proliferation

  2019cites this paper
• Long-term effect of low-dose imatinib therapy for pulmonary hypertension due to chronic degenerative mitral valve disease in six dogs

  2018cites this paper
• Involvement of platelet‐derived growth factor ligands and receptors in tumorigenesis

  2018cites this paper
• PDGF-BB regulates the pulmonary vascular tone: impact of prostaglandins, calcium, MAPK- and PI3K/AKT/mTOR signalling and actin polymerisation in pulmonary veins of guinea pigs

  2018cites this paper
• Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension

  2018cites this paper
• Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats

  2018cites this paper
• Pharmacotherapy for Pulmonary Hypertension: Future Directions

  2017cites this paper
• Imatinib relaxes the pulmonary venous bed of guinea pigs

  2017influential citation
• Involvement of PDGF ligands and receptors in tumorigenesis

  2017cites this paper
• Targeting the Cause, affecting the Course: Characterization and Optimization of Experimental Models for Pulmonary Arterial Hypertension

  2016cites this paper
• Novel Targets of Drug Treatment for Pulmonary Hypertension

  2015cites this paper
• Analysis of cardiovascular responses to the H2S donors Na2S and NaHS in the rat.

  2015cites this paper
• Chronic thromboembolic pulmonary arterial hypertension: a review of the literature and novel therapeutic approaches

  2015cites this paper
• Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension.

  2015cites this paper
• Analysis of erectile responses to H2S donors in the anesthetized rat.

  2015cites this paper
• Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment

  2014cites this paper
• A novel vascular homing peptide strategy to selectively enhance pulmonary drug efficacy in pulmonary arterial hypertension.

  2014cites this paper
• Original Article Sildenefil increases connexin 40 in smooth muscle cells through activation of BMP pathways in pulmonary arterial hypertension

  2014cites this paper
• Enhancing the effectiveness of human cardiac stem cell therapy with the HO-1 inducer-Cobalt Protoporphyrin (CoPP)

  2014cites this paper
• Sildenefil increases connexin 40 in smooth muscle cells through activation of BMP pathways in pulmonary arterial hypertension.

  2014cites this paper
• Vasodilator responses to acetylcholine are not mediated by the activation of soluble guanylate cyclase or TRPV4 channels in the rat.

  2014cites this paper